Research articlePublished 21 May 2021
In-Hospital Clinical Outcomes of Covid-19 Patients Treated with Oral Anticoagulants.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: We aimed to investigate the effects of warfarin and new-generation oral anticoagulants on the prognosis of patients diagnosed with coronavirus disease 2019 (COVID-19). Materials and methods: Patients diagnosed with COVID-19 were divided into two groups depending on whether they were using warfarin or a new-generation oral anticoagulant. The types of chronic diseases, drugs used, haematological and biochemical parameters and prognoses in each group were statistically analysed. Results: Twenty-three patients (37.1%) using warfarin and 39 (62.9%) patients using new-generation oral anticoagulants were included in the study. There was no significant difference between the two groups in terms of demographic characteristics and laboratory data. The mortality rates for the warfarin and new-generation anticoagulant groups were similar (39.1% vs. 43.6%, respectively; p=0.731). Conclusion: There was no difference in the effects of warfarin and new-generation oral anticoagulants on mortality among the patients with COVID-19.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Lettre
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Salih Sahinkus”
- BylineArticles whose byline prints “Ercan Aydin”
- BylineArticles whose byline prints “Ahmet Cihad Genc”
- BylineArticles whose byline prints “Selçuk Yaylaci”